期刊文献+

Cellular reprogramming and inherited peripheral neuropathies: perspectives and challenges

Cellular reprogramming and inherited peripheral neuropathies: perspectives and challenges
下载PDF
导出
摘要 Inherited peripheral neuropathies (or Charcot-Marie-Tooth disease, CMT) are a phenotypically and genetically heterogeneous group of disorders, which are currently untreatable. They are the most common inherited neuromuscular disorder, affecting around 1 in every 2,500 people (over 120,000 people in the US). Based on clinical neurophysiological and histopathological features, inherited neuropathies can be divided into two major forms: demyelinating (type 1) and axonal (type 2) CMT (Saporta, 2014). Inherited peripheral neuropathies (or Charcot-Marie-Tooth disease, CMT) are a phenotypically and genetically heterogeneous group of disorders, which are currently untreatable. They are the most common inherited neuromuscular disorder, affecting around 1 in every 2,500 people (over 120,000 people in the US). Based on clinical neurophysiological and histopathological features, inherited neuropathies can be divided into two major forms: demyelinating (type 1) and axonal (type 2) CMT (Saporta, 2014).
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2015年第6期894-896,共3页 中国神经再生研究(英文版)
  • 相关文献

参考文献10

  • 1Adebola AA, Di Castri T, He CZ, Salvatierra LA, Zhao J, Brown K, Lin CS, Worman HI, Liem RK (2015) Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnor- malities and a Charcot-Marie-Tooth Type 2E phenotype. Hum Mol Genet 24:2163-2174.
  • 2Donnelly CJ, Zhang PW, Pham IT, Haeusler AR, Mistry NA, Vidensky S, Daley EL, Poth EM, Hoover B, Fines DM, Maragakis N, Tienari PJ, Petrucelli L, Traynor BJ, Wang J, Rigo F, Bennett CF, Blackshaw S, Sattler R, Rothstein JD (2013) RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80:415-428.
  • 3Lee (;, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, Fasano CA, Ganat YM, Menon J, Shimizu F, Viale A, Tabar V, Sadelain M, Studer L (2009) Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461:402-406.
  • 4Liu Q, Spusta SC, Mi R, Lassiter RN, Stark MR, H6ke A, Rao MS, Zeng X (2012) Human neural crest stem cells derived from human ESCs and induced pluripotent stem cells: induction, maintenance, and differentiation into functional schwann cells. Stem Cells Transl Med 1:266-278.
  • 5Maury Y, C6me J, Piskorowski RA, Salah-Mohellibi N, Chevaleyre V, Peschanski M, Martinat C, Nedelec S (2014) Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat Biotechnol 33:89-96.
  • 6Saporta MA (2014) Charcot-marie-tooth disease and other inherited neuropathies. Continuum (Minneap Minn) 20:1208-1225.
  • 7Saporta MA, Dang V, Volfson D, Zou B, Xie XS, Adebola A, Liem RK, Shy M, Dimos JT (2015) Axonal Charcot-Marie-Tooth disease pa- tient-derived motor neurons demonstrate disease-specific pheno- types including abnormal electrophysiological properties. Exp Neu- rol 263:190-199.
  • 8Saporta MA, Grskovic M, Dimos IT (201 l) Induced pluripotent stem cells in the study of neurological diseases. Stem Cell Res Ther 2:37.
  • 9Sareen D, O'Rourke JG, Meera P, Muhammad AK, Grant S, Simpkinson M, Bell S, Carmona S, Ornelas L, Sahabian A, Gendron T, Petrucelli L, Baughn M, Ravits J, Harms MB, Rigo F, Bennett CF, Otis TS, Svend- sen CN, Baloh RH (2013) Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med 5:208ra149.
  • 10Umbach JA, Adams KL, Gundersen CB, Novitch BG (2012) Functional neuromuscular junctions formed by embryonic stem cell-derived motor neurons. PLoS One 7:e36049.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部